Capvizr
THE DEAL, AT A GLANCE

Wuxi Laitakang

From the announcement
01Who is involvedBacked by Lapam Capital, continued investment from K2 Venture Partners, GL VenturesFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedWuxi Laitakang raised Series A, announced 2026-11-12From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersWuxi Laitakang's Series A is recorded at $0M in Unclassified, a category with 967 other funding rounds in the trailing 30 days.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Wuxi Laitakang · Financing Record

Explore source-linked visual explanations for Wuxi Laitakang. Unsupported claims are withheld while source review continues.

Record 15941 · Recorded date: 2026-11-12

What it does

Wuxi Laitakang: illustrative category image
Illustrative image (biotech lab), not Wuxi Laitakang's product · Stephane Lesbats (IFREMER, Pôle Images, Centre Bretagne - ZI / CC BY 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 15941 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime